Genoplan
#221 Fias, 4-1 Kyudai Shinmachi, Nishi-Ku, Fukuoka City, Fukuoka, 819-0388, Japan
Overview
Genoplan positions itself around cutting-edge medical technology and scientific innovation, stating its mission to help reshape customers' futures. The company maintains a homepage at www.genoplan.com. According to the listing, Genoplan completed a $15M Series B in November 2018. Participating investors listed include Softbank Ventures Asia, Samsung Ventures, Green Cross, Dayli Partners, and PIA Investment Management. The article presents Genoplan as a portfolio company of SparkLabs Korea. The article provides no operating metrics, product details, or further financial information beyond the Series B.
- Total raised
- $15M
- Funding rounds
- 1
- Latest round
- Series B
- Latest activity
- Apr 2017
Industries
- Artificial Intelligence (AI)
- Biotechnology
- Genetics
- Health Care
- InsurTech
- Life Science
- Machine Learning
- Predictive Analytics
Recent funding
Series B
Apr 2017
$15M
Team
No current team members are available.